Patent · US Active

Anti-IL1RAP antibodies and antibody drug conjugates

US11248054B2 · kind B2 · utility

0Cited by
35References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 12, 2018
Grant dateFeb 15, 2022
Priority date—
Expiry dateJun 12, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are Interleukin 1 Receptor Accessory Protein (IL1RAP) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.